Skip to main content
. 2022 Sep 30;12:16396. doi: 10.1038/s41598-022-20657-y

Figure 1.

Figure 1

Schematic presentation of the overall experimental design outlining the exposure regimen and endpoints. ALI: air–liquid interface; alv-ALI: alveolar mucosa model at ALI; bro-ALI: bronchial mucosa model at ALI; h: hours; H441: NCI-H441 (ATCC HTB-174) cell line; HTP: heated tobacco product; IFNγ: interferon gamma; IL: interleukin; IQOS: I quit ordinary smoking; LDH: lactate dehydrogenase; MDA: malondialdehyde; NFkB: nuclear factor kappa-light-chain-enhancer of activated B cells; PARP: cleaved poly [ADP-Ribose] polymerase; PBEC: human primary bronchial epithelial cells; TNFα: tumor necrosis factor alpha; γH2AX: phosphorylated histone H2AX.